Cosmochemistry techniques shed light on potential new Alzheimer’s disease biomarker

The study identifies lower potassium isotope ratios in Alzheimer’s patients, suggesting δ41K as a viable biomarker for early detection of the disease.

Government announces plans to bring new legislation on visiting in health and care settings

People in care homes and hospitals will be able to have visitors in all circumstances, thanks to the government’s plans to bring forward new legislation.

June 21, 2023

The VPAS fallout continues – Celltrion pulls high-profile biosimilar from UK market – Pharmaceutical Technology

Celltrion had voiced initial worries about the likely unsustainability of the 2023 VPAS rate long before it was set last December. Credit: Pavel Kapysh /

July 3, 2023

PreciseDx Raises $20.7M for AI-Powered Cancer Risk Assessments

What You Should Know: – PreciseDx, a pioneering company in oncology diagnostics utilizing artificial intelligence (AI) raises $20.7M in Series B funding led by Eventide

August 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.